aluxum RxSight (NASDAQ:RXST), a maker of light-adjustable intraocular lenses, traded lower on Friday after Stifel
Summary: Johnson & Johnson’s diversified revenue streams, significant presence in oncology and immunotherapy, and aggressive
hapabapa Johnson & Johnson (NYSE:JNJ) has announced that the U.S. FDA has declined to approve
iQoncept/iStock via Getty Images Short interest for healthcare stocks in S&P 500 rose in November
Henadzi Pechan/iStock via Getty Images Johnson & Johnson (NYSE:JNJ) has submitted a supplemental Biologics License
Igor Kutyaev A weekly summary of insider trading highlighting notable buying and selling by investors,
Mario Tama Johnson & Johnson (NYSE:JNJ) has sued two units of health insurer Cigna (NYSE:CI),
Johnson & Johnson (NYSE:JNJ) shares traded in the green on Monday, snapping six consecutive days
Summary: Recent market concerns have pressured the stock prices of both Johnson & Johnson and
Sundry Photography/iStock Editorial via Getty Images Johnson & Johnson (NYSE:JNJ) submitted two supplemental Biologics License